AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

IRON ROAD LTD

0.009

-0.001-10.00%

Volume:34.03K

Turnover:306

Market Cap:7.56M

PE:-0.08

High:0.009

Open:0.009

Low:0.009

Close:0.010

52wk High:0.060

52wk Low:0.007

Shares:840.19M

Float Shares:216.26M

Volume Ratio:0.06

T/O Rate:0.02%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.119

EPS(LYR):0.006

ROE:-111.74%

ROA:-1.48%

PB:0.19

PE(LYR):1.58

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Top Midday Gainers

MT Newswires Live

Wedbush Raises Opus Genetics Price Target to $13 From $10, Maintains Outperform Rating

MT Newswires Live

RBC Adjusts PT on Opus Genetics to $9 From $10, Maintains Outperform Speculative Risk Rating

MT Newswires Live

Opus Genetics Completes Enrollment in Phase 3 Gene Therapy Trial for Rare Blindness Disorder

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnest.com/stock/IRD.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"IRD.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"IRD.AU\",,,,,undefined,":{"symbol":"IRD.AU","market":"AU","secType":"STK","nameCN":"IRON ROAD LTD","latestPrice":0.009,"timestamp":1789020720000,"preClose":0.01,"halted":0,"volume":34028,"delay":0,"changeRate":-0.10000000000000009,"nameEN":"IRON ROAD LTD","floatShares":216255163,"shares":840192775,"eps":-0.118753,"marketStatus":"Not Yet Opened","change":-0.001,"latestTime":"09-10 16:12:00 AEST","open":0.009,"high":0.009,"low":0.009,"amount":306,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.118753,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1789084800000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.01,"openAndCloseTimeList":[[1788998400000,1789020000000]],"volumeRatio":0.06329434136139177,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"IRD.AU","preClose":0.01,"auctionPrice":0.01,"auctionVolume":100000,"auction":3,"marketStatus":"盘后竞价","timestamp":1788933600689}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"IRD.AU\",,,,,undefined,":{"symbol":"IRD.AU","floatShares":216255163,"roa":"-1.48%","roe":"-111.74%","lyrEps":0.005699,"volumeRatio":0.06329434136139177,"shares":840192775,"dividePrice":0,"high":0.009,"amplitude":0,"preClose":0.01,"low":0.009,"week52Low":0.007,"pbRate":"0.19","psRate":"106.21","week52High":0.06,"institutionHeld":0,"latestPrice":0.009,"eps":-0.118753,"divideRate":0,"volume":34028,"delay":0,"ttmEps":-0.118753,"open":0.009,"prevYearClose":0.024,"prevWeekClose":0.011,"prevMonthClose":0.007,"prevQuarterClose":0.011,"fiveDayClose":0.011,"twentyDayClose":0.015,"sixtyDayClose":0.013,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IRD.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2020-11-11","symbol":"IRD.AU","type":"split","dateTimestamp":1605013200000,"forFactor":991666,"toFactor":1000000,"ratio":0.991666}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IRD.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IRD.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666532138","title":"Top Midday Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2666532138","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666532138?lang=en_us&edition=fundamental","pubTime":"2026-09-10 02:05","pubTimestamp":1788977158,"startTime":"0","endTime":"0","summary":"SUNation Energy  shares surged 60% after Suniva reported late Tuesday the close of an $835 million capital raise. The duo struck a reverse merger deal in June.Intraday trading volume catapulted to over 70.8 million from a daily average of about 2.5 million.InnovAge  swung to a profit in fiscal Q4 following a better-than-expected sales growth.Shares jumped 8%, with intraday trading volume rising to over 612,000 from a daily average of about 317,000.Opus Genetics  said Wednesday patients with BEST1-related retinal diseases showed clinically meaningful improvement in visual function in the low-dose cohort 1 of its BIRD-1 phase 1/2 clinical trial evaluating OPGx-BEST1.Wedbush Securities raised its price target for the stock to $13 from $10 while maintaining its outperform rating.Shares surged 25% as intraday trading volume soared to over 43.6 million from a daily average of roughly 1.1 million.Price: 3.85, Change: +1.48, Percent Change: +62.24","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MARS","IRD.AU","BK4007","DIPR","ROKT","ORBX","BK4089","BK4564","INNV","IRD","XTL","BK7129","BK4139","LU0054578231.USD","WARP","BK4196","SUNE","IRDM","BK4096","COWG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666534593","title":"Wedbush Raises Opus Genetics Price Target to $13 From $10, Maintains Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2666534593","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666534593?lang=en_us&edition=fundamental","pubTime":"2026-09-10 00:34","pubTimestamp":1788971698,"startTime":"0","endTime":"0","summary":"Opus Genetics (IRD) has an average rating of buy and mean price target of $10.71, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IRD","BK4139","BK4007","BK7129","IRD.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657454976","title":"RBC Adjusts PT on Opus Genetics to $9 From $10, Maintains Outperform Speculative Risk Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2657454976","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657454976?lang=en_us&edition=fundamental","pubTime":"2026-08-07 20:35","pubTimestamp":1786106149,"startTime":"0","endTime":"0","summary":"Opus Genetics (IRD) has an average rating of buy and mean price target of $10.71, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","IRD.AU","BK4007","IRD","BK7129"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656796513","title":"Opus Genetics Completes Enrollment in Phase 3 Gene Therapy Trial for Rare Blindness Disorder","url":"https://stock-news.laohu8.com/highlight/detail?id=2656796513","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656796513?lang=en_us&edition=fundamental","pubTime":"2026-08-03 20:24","pubTimestamp":1785759877,"startTime":"0","endTime":"0","summary":"Opus Genetics  completed enrollment in its phase 3 registrational trial evaluating OPGx-LCA5, an investigational gene therapy for LCA5-associated inherited retinal disease, a rare condition that can cause blindness, the company said on Monday.The trial was developed in collaboration with the US FDA and could support a future Biologics License Application.Opus expects to begin dosing patients in Q4 and report topline data by the end of 2027. OPGx-LCA5 has received FDA Rare Pediatric Disease, Orphan Drug and RMAT designations, it said.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IRD.AU","BK4007","BK4139","BK7129","IRD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":3,"pageCount":1,"totalSize":11,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/IRD.AU\",params:#limit:6,delay:true,,,undefined,":[]}}